D. Pectasides

发表

Array-based pharmacogenomics of molecular-targeted therapies in oncology

D. Sanoudou, G. Mountzios, D. Arvanitis, 2012, The Pharmacogenomics Journal.

Successful treatment of adult patients with idiopathic recurrent pericarditis with an interleukin-1 receptor antagonist (anakinra).

C. Tsioufis, C. Stefanadis, D. Vassilopoulos, 2012, International journal of cardiology.

XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis

K. Syrigos, T. Economopoulos, G. Fountzilas, 2012, BMC Cancer.

Impact of tumor angiogenic profile on the outcome of patients with metastatic breast carcinoma treated with weekly docetaxel. A Hellenic Cooperative Oncology Group (HeCOG) study.

G. Aravantinos, G. Fountzilas, P. Kosmidis, 2015, Histology and histopathology.

HER-2/neu status of primary breast cancer and corresponding metastatic sites in patients with advanced breast cancer treated with trastuzumab-based therapy.

T. Economopoulos, P. Arapantoni-Dadioti, D. Pectasides, 2006, Anticancer research.

Merkel cell cancer of the skin.

T. Economopoulos, D. Pectasides, M. Pectasides, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study

G. Aravantinos, H. Kalofonos, G. Fountzilas, 2010, BMC medicine.

Cyclin D1 differential activation and its prognostic impact in patients with advanced breast cancer treated with trastuzumab

G. Lazaridis, G. Aravantinos, K. Papadopoulou, 2019, ESMO Open.

Evaluation of the prognostic value of all four HER family receptors in patients with metastatic breast cancer treated with trastuzumab: A Hellenic Cooperative Oncology Group (HeCOG) study

G. Lazaridis, A. Psyrri, K. Papadopoulou, 2018, PloS one.

PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patients

G. Aravantinos, H. Kalofonos, G. Fountzilas, 2015, Cancer Chemotherapy and Pharmacology.

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer

K. Milde-Langosch, R. Wirtz, F. Jänicke, 2010, British Journal of Cancer.

Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study

M. Dimopoulos, U. Dafni, H. Gogas, 2008, British Journal of Cancer.

Paclitaxel and bevacizumab as first line combined treatment in patients with metastatic breast cancer: the Hellenic Cooperative Oncology Group experience with biological marker evaluation.

G. Fountzilas, G. Pentheroudakis, C. Papandreou, 2011, Anticancer research.

Correlation of molecular human leukocyte antigen typing and outcome in high-risk melanoma patients receiving adjuvant interferon

V. Sondak, U. Dafni, J. Kirkwood, 2010, Cancer.

Tolerability of adjuvant high-dose interferon alfa-2b: 1 month versus 1 year--a Hellenic Cooperative Oncology Group study.

H. Gogas, G. Fountzilas, D. Pectasides, 2004, Anticancer research.

Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized phase III study conducted by the Hellenic Cooperative Oncology Group.

U. Dafni, H. Gogas, C. Markopoulos, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Correlation of Abdominal Computed Tomography Scanning and Second‐Look Operation Findings in Ovarian Cancer Patients

D. Pectasides, H. Kayianni, A. Facou, 1991, American journal of clinical oncology.

Evaluation of liver fibrosis by transient elastography (FibroScan®) in rheumatic patients during methotrexate treatment

D. Vassilopoulos, D. Pectasides, S. Manolakopoulos, 2016 .

Non-Hodgkin’s Lymphomas in Greece according to the WHO Classification of Lymphoid Neoplasms

M. Dimopoulos, N. Pavlidis, T. Economopoulos, 2005, Acta Haematologica.

Clinical value of CA 15-3, mucin-like carcinoma-associated antigen, tumor polypeptide antigen, and carcinoembryonic antigen in monitoring early breast cancer patients.

N. Pavlidis, D. Pectasides, D Pectasides, 1996, American journal of clinical oncology.

Squamous cell carcinoma antigen, circulating immune complexes, and immunoglobulins in monitoring squamous cell carcinoma of head and neck: a study of the hellenic co-operative oncology group (HeCOG).

G. Fountzilas, D. Pectasides, P. Makrantonakis, 1999, American journal of clinical oncology.

Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study

F. Fostira, D. Yannoukakos, H. Gogas, 2012, Breast Cancer Research and Treatment.

Lessons from the past: Long-term safety and survival outcomes of a prematurely terminated randomized controlled trial on prophylactic vs. hemoglobin-based administration of erythropoiesis-stimulating agents in patients with chemotherapy-induced anemia.

G. Aravantinos, G. Fountzilas, G. Mountzios, 2016, Molecular and clinical oncology.

Gemcitabine versus Gemcitabine–Carboplatin for Patients with Advanced Non-small Cell Lung Cancer and a Performance Status of 2: A Prospective Randomized Phase II Study of the Hellenic Cooperative Oncology Group

M. Dimopoulos, K. Syrigos, I. Boukovinas, 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Phosphatidylinositol 3′-Kinase Catalytic Subunit α Gene Amplification Contributes to the Pathogenesis of Mantle Cell Lymphoma

A. Scorilas, A. Psyrri, T. Economopoulos, 2009, Clinical Cancer Research.

Genotyping data of routinely processed matched primary/metastatic tumor samples

E. Giannoulatou, K. Papadopoulou, G. Fountzilas, 2020, Data in brief.

Multiplex RT-PCR-based detections of CEA, CK20 and EGFR in colorectal cancer patients.

M. Koutsilieris, D. Pectasides, D. Korkolis, 2010, World journal of gastroenterology.

Expression of angiogenic markers in the peripheral blood of patients with advanced breast cancer treated with weekly docetaxel.

G. Fountzilas, D. Pectasides, H. Linardou, 2012, Anticancer research.

Developments in the systemic treatment of metastatic cervical cancer.

M. Dimopoulos, A. Soultati, G. Mountzios, 2013, Cancer treatment reviews.

Novel Approaches for Concurrent Irradiation in Locally Advanced Cervical Cancer: Platinum Combinations, Non-Platinum-Containing Regimens, and Molecular Targeted Agents

M. Dimopoulos, A. Soultati, G. Mountzios, 2013, Obstetrics and gynecology international.

Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: A phase II Trial of the Hellenic Cooperative Oncology Group.

H. Gogas, K. Pavlakis, H. Kalofonos, 2010, Clinical breast cancer.

A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group Study.

C. Papadimitriou, T. Economopoulos, H. Kalofonos, 2008, European journal of cancer.

Vascular endothelial growth factor polymorphisms and clinical outcome in colorectal cancer patients treated with irinotecan-based chemotherapy and bevacizumab

F. Fostira, A. Antonacopoulou, H. Kalofonos, 2011, The Pharmacogenomics Journal.

Paclitaxel and gemcitabine versus paclitaxel and vinorelbine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group (HeCOG).

M. Dimopoulos, K. Syrigos, H. Kalofonos, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical value of bone remodelling markers in patients with bone metastases treated with zoledronic acid.

T. Economopoulos, S. Raptis, D. Farmakis, 2005, Anticancer research.

Diagnostic value of bone remodeling markers in the diagnosis of bone metastases in patients with breast cancer.

T. Economopoulos, S. Raptis, D. Farmakis, 2005, Journal of pharmaceutical and biomedical analysis.

Weekly chemotherapy with carboplatin, docetaxel and irinotecan in advanced non-small-cell-lung cancer: a phase II study.

D. Pectasides, A. Kouloubinis, A. Athanassiou, 2002, European journal of cancer.

Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II study.

D. Farmakis, D. Pectasides, M. Pectasides, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Brain metastases from epithelial ovarian cancer: a review of the literature.

T. Economopoulos, D. Pectasides, M. Pectasides, 2006, The oncologist.

An out-patient second-line chemotherapy with gemcitabine and vinorelbine in patients with non-small cell lung cancer previously treated with cisplatin-based chemotherapy. A phase II study of the Hellenic co-operative Oncology Group.

H. Kalofonos, G. Fountzilas, D. Pectasides, 2001, Anticancer research.

Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin.

R. Wirtz, W. Grady, G. Fountzilas, 2016, Clinical colorectal cancer.

Postoperative dose-dense sequential chemotherapy with epirubicin, paclitaxel and CMF in patients with high-risk breast cancer: safety analysis of the Hellenic Cooperative Oncology Group randomized phase III trial HE 10/00.

U. Dafni, H. Gogas, C. Markopoulos, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.

H. Gogas, G. Aravantinos, K. Papadopoulou, 2017, Cancer genomics & proteomics.

Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial

H. Gogas, C. Papadimitriou, C. Markopoulos, 2022, British Journal of Cancer.

Treatment issues in clear cell carcinoma of the ovary: a different entity?

A. Psyrri, T. Economopoulos, D. Pectasides, 2006, The oncologist.

Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03).

M. Dimopoulos, U. Dafni, A. Psyrri, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Vinorelbine versus paclitaxel for patients with advanced non-small cell lung cancer (NSCLC) and a performance status of 2.

M. Dimopoulos, K. Syrigos, I. Boukovinas, 2012, Anticancer research.

Combination chemotherapy with docetaxel, vinorelbine and estramustine phosphate in metastatic androgen-resistant prostate cancer: a single institution experience.

A. Psyrri, T. Economopoulos, K. Kamposioras, 2009, Anticancer research.

Docetaxel and intermittent erlotinib in patients with metastatic Non-Small Cell Lung Cancer; a phase II study from the Hellenic Cooperative Oncology Group.

M. Dimopoulos, K. Syrigos, I. Boukovinas, 2014, Anticancer research.

Feasibility of Induction Docetaxel, Cisplatin, 5-Fluorouracil, Cetuximab (TPF-C) Followed by Concurrent Cetuximab Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

A. Psyrri, T. Economopoulos, A. Zygogianni, 2013, Front. Oncol..

Gemcitabine plus pegylated liposomal doxorubicin in patients with advanced epithelial ovarian cancer resistant/refractory to platinum and/or taxanes. A HeCOG phase II study.

M. Dimopoulos, N. Pavlidis, H. Gogas, 2005, Anticancer research.

Bevacizumab in combination with chemotherapy for the treatment of advanced ovarian cancer: a systematic review

G. Aravantinos, D. Pectasides, 2014, Journal of Ovarian Research.

Diastolic myocardial dysfunction does not affect survival in patients with cirrhosis

C. Chrysohoou, D. Pectasides, G. Papatheodoridis, 2012, Transplant international : official journal of the European Society for Organ Transplantation.

Left ventricle enlargement and increased systolic velocity in the mitral valve are indirect markers of the hepatopulmonary syndrome

C. Chrysochoou, D. Pectasides, G. Papatheodoridis, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Post-operative combined radiation and chemotherapy with temozolomide and irinotecan in patients with high-grade astrocytic tumors. A phase II study with biomarker evaluation.

M. Ignatiadis, P. Selviaridis, G. Fountzilas, 2006, Anticancer research.

Treatment of non-small cell lung cancer with gefitinib (‘Iressa’, ZD1839): the Greek experience with a compassionate-use program

M. Dimopoulos, G. Fountzilas, D. Pectasides, 2005, Anti-cancer drugs.

Epithelial ovarian cancer in Greece: a retrospective study of 1,791 patients by the Hellenic Cooperative Oncology Group (HeCOG).

M. Dimopoulos, N. Pavlidis, T. Economopoulos, 2009, Anticancer research.

Maintenance or Consolidation Therapy in Advanced Ovarian Cancer

D. Pectasides, E. Pectasides, 2007, Oncology.

Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer

H. Gogas, T. Economopoulos, G. Fountzilas, 2006, Medical oncology.

Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology Group.

M. Dimopoulos, U. Dafni, H. Gogas, 2008, Anticancer research.

Oxaliplatin and irinotecan plus granulocyte-colony stimulating factor as third-line treatment in relapsed or cisplatin-refractory germ-cell tumor patients: a phase II study.

G. Aravantinos, T. Economopoulos, S. Raptis, 2004, European urology.

Prognostic Subcellular Notch2, Notch3 and Jagged1 Localization Patterns in Early Triple-negative Breast Cancer.

H. Gogas, G. Lazaridis, G. Aravantinos, 2017, Anticancer research.

Adalimumab decreases aortic stiffness independently of its effect in disease activity in patients with rheumatoid arthritis

C. Vlachopoulos, C. Stefanadis, D. Vassilopoulos, 2015, Clinical Rheumatology.

Myelotoxicity of oral topotecan in relation to treatment duration and dosage: a phase I study

D. Trafalis, D. Pectasides, A. Anagnostopoulos, 2010, Anti-cancer drugs.

Immunoscintigraphy with 131I‐labelled monoclonal antibodies HMFG2 and HMFG1 F(ab')2 versus abdominal CT scan in the detection of residual disease in ovarian cancer patients

J. Taylor‐Papadimitriou, D. Pectasides, A. Epenetos, 1988, International journal of cancer. Supplement = Journal international du cancer. Supplement.

Immunoscintigraphy with 131I‐labelled HMFG2 and HMFG2 F(ab')2 in the pre‐operative detection of clinical and subclinical lymph node metastases in breast cancer patients

J. Taylor‐Papadimitriou, D. Pectasides, A. Epenetos, 1988, International journal of cancer. Supplement = Journal international du cancer. Supplement.

Epithelial ovarian cancer: focus on targeted therapy.

D. Pectasides, K. Pliarchopoulou, 2011, Critical reviews in oncology/hematology.

Platinum-Based Chemotherapy of Primary Extragonadal Germ Cell Tumours: The Hellenic Cooperative Oncology Group Experience

G. Fountzilas, D. Pectasides, D. Skarlos, 1999, Oncology.

Investigation of prognostic biomarkers in patients with urothelial carcinoma treated with platinum-based regimens.

F. Fostira, A. Charchanti, A. Psyrri, 2022, Urologic oncology.

Angiogenic and Antiangiogenic VEGFA Splice Variants in Colorectal Cancer: Prospective Retrospective Cohort Study in Patients Treated With Irinotecan-Based Chemotherapy and Bevacizumab.

K. Papadopoulou, G. Fountzilas, G. Pentheroudakis, 2019, Clinical colorectal cancer.

Combination treatment with metronomic temozolomide, bevacizumab and long-acting octreotide for malignant neuroendocrine tumours

G. Kaltsas, D. Rontogianni, G. Dimitriadis, 2012, Endocrine-related cancer.

Iron deficiency anemia in chronic liver disease: etiopathogenesis, diagnosis and treatment

D. Pectasides, M. Deutsch, E. Gkamprela, 2017, Annals of gastroenterology.

How to Manage Melanoma in a Psoriatic Patient

A. Psyrri, E. Papadavid, D. Pectasides, 2008, Dermatology.

Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: a Hellenic Cooperative Oncology Group (HeCOG) study.

G. Aravantinos, H. Kalofonos, G. Fountzilas, 2011, Oncology reports.

Multifocal extranodal non-hodgkin lymphoma: a clinicopathologic study of 37 cases in Greece, a Hellenic Cooperative Oncology Group study.

M. Dimopoulos, T. Economopoulos, S. Papageorgiou, 2005, The oncologist.

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE).

M. Lux, R. Greil, A. Schneeweiss, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Fallopian tube carcinoma: a review.

T. Economopoulos, D. Pectasides, E. Pectasides, 2006, The oncologist.

Combination chemotherapy with carboplatin, docetaxel, and gemcitabine in advanced non-small-cell lung cancer: a phase II study.

D. Pectasides, A. Kalantaridou, A. Athanassiou, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of docetaxel and docetaxel-irinotecan combination as second-line chemotherapy in advanced non-small-cell lung cancer: a randomized phase II trial.

T. Economopoulos, S. Raptis, D. Farmakis, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Cancer. A Hellenic Cooperative Oncology Group Phase I/II Study

G. Fountzilas, G. Pentheroudakis, C. Dervenis, 2018, Targeted Oncology.

Methotrexate, paclitaxel, ifosfamide, and cisplatin in poor-risk nonseminomatous germ cell tumors.

T. Economopoulos, K. Kamposioras, D. Pectasides, 2010, Urologic oncology.

First Line Gemcitabine/Pazopanib in Locally Advanced and/or Metastatic Biliary Tract Carcinoma. A Hellenic Cooperative Oncology Group Phase II Study

G. Aravantinos, A. Psyrri, G. Fountzilas, 2020, AntiCancer Research.

Current management of stage I testicular non-seminomatous germ cell tumours.

D. Pectasides, A. Constantinidou, G. Aravantinos, 2009, Critical reviews in oncology/hematology.

Late complications of chemotherapy in testicular cancer.

D. Pectasides, K. Pliarchopoulou, 2010, Cancer treatment reviews.

Germ cell tumors of the ovary.

D. Pectasides, D. Kassanos, E. Pectasides, 2008, Cancer treatment reviews.

Chemotherapy for recurrent cervical cancer.

K. Kamposioras, D. Pectasides, G. Papaxoinis, 2008, Cancer treatment reviews.

Testicular function in patients with testicular cancer treated with bleomycin-etoposide-carboplatin (BEC(90)) combination chemotherapy.

D. Farmakis, D. Pectasides, M. Pectasides, 2004, European urology.

Brain metastases from epithelial ovarian cancer. The Hellenic Cooperative Oncology Group (HeCOG) experience and review of the literature.

M. Dimopoulos, G. Aravantinos, T. Economopoulos, 2005, Anticancer research.

Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases

C. Stefanadis, D. Vassilopoulos, D. Pectasides, 2014, Annals of the rheumatic diseases.

Recent advances in conventional-dose salvage chemotherapy in patients with cisplatin-resistant or refractory testicular germ cell tumors.

D. Farmakis, D. Pectasides, M. Pectasides, 2005, European urology.

The Management of Stage I Nonseminomatous Testicular Germ Cell Tumors

D. Farmakis, D. Pectasides, M. Pectasides, 2007, Oncology.

Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data.

N. Pavlidis, K. Syrigos, G. Fountzilas, 2006, Anticancer research.

First line combination chemotherapy with cisplatin and etoposide in advanced ovarian cancer.

D. Pectasides, I. Varthalitis, D. Bafaloukos, 1989, British Journal of Cancer.

Vinorelbine in Combination with Interleukin-2 as Second-Line Treatment in Patients with Metastatic Melanoma. A Phase II Study of the Hellenic Cooperative Oncology Group

H. Gogas, G. Fountzilas, D. Pectasides, 2004, Cancer investigation.

Granulosa cell tumor of the ovary.

A. Psyrri, D. Pectasides, E. Pectasides, 2008, Cancer treatment reviews.

Testicular function in poor-risk nonseminomatous germ cell tumors treated with methotrexate, paclitaxel, ifosfamide, and cisplatin combination chemotherapy.

A. Psyrri, T. Economopoulos, D. Pectasides, 2009, Journal of andrology.

Androgen Receptor and PIM1 Expression in Tumor Tissue of Patients With Triple-negative Breast Cancer

H. Gogas, G. Aravantinos, C. Petraki, 2021, Cancer Genomics & Proteomics.

A randomized trial to compare the efficacy and safety of antiemetic treatment with ondansetron and ondansetron zydis in patients with breast cancer treated with high-dose epirubicin.

U. Dafni, N. Pavlidis, G. Aravantinos, 2007, Anticancer research.

Combination chemotherapy with cisplatin, etoposide and irinotecan in patients with extensive small-cell lung cancer: A phase II study of the Hellenic Co-operative Oncology Group.

M. Dimopoulos, K. Syrigos, T. Economopoulos, 2007, Lung cancer.

Comparison of filgrastim and pegfilgrastim to prevent neutropenia and maintain dose intensity of adjuvant chemotherapy in patients with breast cancer

M. Dimopoulos, H. Gogas, G. Fountzilas, 2015, Supportive Care in Cancer.

Dermatomyositis associated with breast cancer.

T. Economopoulos, D. Pectasides, M. Pectasides, 2006, Anticancer research.

Cisplatin-Based Chemotherapy for Merkel Cell Carcinoma of the Skin

A. Psyrri, T. Economopoulos, D. Pectasides, 2006, Cancer investigation.

Vascular endothelial growth factor polymorphisms and clinical outcome in patients with metastatic breast cancer treated with weekly docetaxel

C. Papadimitriou, H. Kalofonos, K. Papadopoulou, 2013, The Pharmacogenomics Journal.

An Outpatient Phase II Study of Subcutaneous Interleukin-2 and Interferon-Alpha-2b in Combination with Intravenous Vinblastine in Metastatic Renal Cell Cancer

D. Pectasides, M. Kostopoulou, M. Papadopoulou, 1997, Oncology.

Two cycles of carboplatin-based adjuvant chemotherapy for high-risk clinical stage I and stage IM non-seminomatous germ cell tumours of the testis: a HECOG trial.

G. Aravantinos, G. Fountzilas, D. Farmakis, 2003, Anticancer Research.

Association between CD8+ Tumor Infiltrating Lymphocytes and the Clinical Outcome of Patients with Operable Breast Cancer Treated with Adjuvant Dose-Dense Chemotherapy—A 10 Year Follow-Up Report of a Hellenic Cooperative Oncology Group Observational Study

A. Charchanti, H. Gogas, G. Aravantinos, 2022, Cancers.

Evaluation of IL-10 polymorphisms in high-risk melanoma patients receiving adjuvant interferon.

H. Gogas, G. Fountzilas, D. Pectasides, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: report of 2 cases with clinical implications.

M. Dimopoulos, A. Psyrri, T. Economopoulos, 2012, Oral surgery, oral medicine, oral pathology and oral radiology.

Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience

S. Giannouli, D. Pectasides, J. Koskinas, 2017, European journal of gastroenterology & hepatology.

Non Small Cell Lung Cancer in the Elderly: Clinico-Pathologic, Management and Outcome Characteristics in Comparison to Younger Patients

T. Economopoulos, G. Fountzilas, D. Pectasides, 2009, Journal of chemotherapy.

Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.

M. Dimopoulos, T. Economopoulos, G. Fountzilas, 2006, Gynecologic oncology.

Treatment of disseminated germ cell tumours of the testis.

D. Pectasides, D. Bafaloukos, V. Barbounis, 1989, British journal of urology.

Treatment of metastatic malignant melanoma with dacarbazine, vindesine and cisplatin.

D. Pectasides, D. Bafaloukos, V. Barbounis, 1989, British Journal of Cancer.

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial

G. Fountzilas, N. Pavlidis, H. Gogas, 2012, Cancer Chemotherapy and Pharmacology.

Common breast cancer susceptibility loci are associated with triple-negative breast cancer.

Jane E. Carpenter, S. Cross, M. Beckmann, 2011, Cancer research.

Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study.

N. Pavlidis, H. Gogas, R. Wirtz, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Merkel Cell Carcinoma of the Skin: A Retrospective Study of 24 Cases by the Hellenic Cooperative Oncology Group

T. Economopoulos, G. Fountzilas, D. Pectasides, 2008, Oncology.

Chemotherapy for Merkel Cell Carcinoma with Carboplatin and Etoposide

D. Pectasides, A. Athanassiou, J. Varthalitis, 1995, American journal of clinical oncology.

Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literature.

N. Pavlidis, G. Pentheroudakis, K. Kamposioras, 2011, Critical reviews in oncology/hematology.

A case report and review of the literature

S. Loukides, N. Kelekis, K. Kamposioras, 2012 .

Stage I testicular seminoma: management and controversies.

D. Pectasides, A. Constantinidou, G. Aravantinos, 2009, Critical reviews in oncology/hematology.

Immunoscintigraphy with 131I-labelled H17E2 monoclonal antibody compared with conventional lymphangiography and computed tomography in the detection of metastases in patients with testicular germ cell tumours.

J. Taylor‐Papadimitriou, D. Pectasides, A. Epenetos, 1990, The British journal of cancer. Supplement.

TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder.

D. Pectasides, A. Athanassiou, L. Gogou, 1996, American journal of clinical oncology.

CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma.

D. Pectasides, D Pectasides, A Mylonakis, 1997, American journal of clinical oncology.

Anthracycline-Based Chemotherapy of Primary Non-Hodgkin’s Lymphoma of the Testis: The Hellenic Cooperative Oncology Group Experience

M. Dimopoulos, A. Antoniou, T. Economopoulos, 2000, Oncology.

Immunoscintigraphy with13"I-labelled H17E2monoclonal antibody compared withconventional lymphangiography andcomputed tomography inthedetection ofmetastases inpatients withtesticular germcelltumours

J. Taylor‐Papadimitriou, D. Pectasides, A. Epenetos, 1990 .

The usefulness of transient elastography in the assessment of patients with HBeAg‐negative chronic hepatitis B virus infection

D. Pectasides, G. Kafiri, M. Deutsch, 2014, Journal of viral hepatitis.

Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy.

D. Pectasides, G. Papatheodoridis, S. Manolakopoulos, 2014, Journal of hepatology.

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer

Jane E. Carpenter, Peter Kraft, Gary K. Chen, 2011, Nature Genetics.

Association of Notch and Hedgehog Pathway Activation With Prognosis in Early-stage Colorectal Cancer

G. Fountzilas, K. Petraki, D. Pectasides, 2019, AntiCancer Research.

MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer

H. Gogas, G. Aravantinos, A. Psyrri, 2016, Journal of Translational Medicine.

TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting

M. Dimopoulos, E. Giannoulatou, H. Gogas, 2016, Oncotarget.

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer

K. Pavlakis, H. Kalofonos, G. Fountzilas, 2011, Breast Cancer Research and Treatment.

Intravenous high‐dose interferon with or without maintenance treatment in melanoma at high risk of recurrence: meta‐analysis of three trials

H. Gogas, A. Marshall, G. Fountzilas, 2015, Cancer medicine.

Evaluation of the Role of p95 HER2 Isoform in Trastuzumab Efficacy in Metastatic Breast Cancer

G. Fountzilas, D. Pectasides, A. Batistatou, 2021, AntiCancer Research.

Prognostic implications of mismatch repair deficiency in patients with nonmetastatic colorectal and endometrial cancer

A. Psyrri, G. Fountzilas, G. Pentheroudakis, 2019, ESMO Open.

Opposite Prognostic Impact of Single PTEN-loss and PIK3CA Mutations in Early High-risk Breast Cancer

E. Giannoulatou, H. Gogas, G. Lazaridis, 2019, Cancer Genomics & Proteomics.

Biomarkers of benefit from cetuximab-based therapy in metastatic colorectal cancer: interaction of EGFR ligand expression with RAS/RAF, PIK3CA genotypes

N. Pavlidis, S. Tejpar, G. Fountzilas, 2013, BMC Cancer.

Identification and Validation of a Multigene Predictor of Recurrence in Primary Laryngeal Cancer

R. Wirtz, G. Fountzilas, E. Veltrup, 2013, PloS one.

Interaction Between Beta-Catenin and EGFR Expression by Immunohistochemistry Identifies Prognostic Subgroups in Early High-risk Triple-negative Breast Cancer.

H. Gogas, G. Aravantinos, G. Fountzilas, 2016, Anticancer research.

The fate of BRCA1-related germline mutations in triple-negative breast tumors.

F. Fostira, D. Yannoukakos, H. Gogas, 2017, American journal of cancer research.

Tumor Genotyping and Homologous Recombination Repair Gene Variants in Patients With Epithelial Ovarian Cancer: Is Pathogenic Enough?

F. Fostira, E. Giannoulatou, G. Aravantinos, 2021, Frontiers in Oncology.

Carboplatin/gemcitabine alternating with carboplatin/pegylated liposomal doxorubicin and carboplatin/cyclophosphamide in platinum-refractory/resistant paclitaxel - pretreated ovarian carcinoma.

A. Psyrri, T. Economopoulos, D. Pectasides, 2010, Gynecologic oncology.

Gemcitabine and pegylated liposomal doxorubicin alternating with cisplatin plus cyclophosphamide in platinum refractory/resistant, paclitaxel-pretreated, ovarian carcinoma.

G. Aravantinos, A. Psyrri, T. Economopoulos, 2008, Gynecologic oncology.

Prognostic Biomarkers in Early-stage Gastric Adenocarcinoma Treated With Adjuvant Chemoradiotherapy

E. Giannoulatou, K. Papadopoulou, G. Fountzilas, 2020, Cancer Genomics & Proteomics.

Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe

E. Giannoulatou, T. Ciuleanu, A. Psyrri, 2018, International journal of cancer.

Developments in the systemic treatment of endometrial cancer.

M. Dimopoulos, G. Mountzios, C. Papadimitriou, 2011, Critical reviews in oncology/hematology.

Systemic therapy in metastatic or recurrent endometrial cancer.

T. Economopoulos, D. Pectasides, E. Pectasides, 2007, Cancer treatment reviews.

Advanced stage mucinous epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience.

M. Dimopoulos, G. Aravantinos, T. Economopoulos, 2005, Gynecologic oncology.

The prognostic and predictive value of mRNA expression of vascular endothelial growth factor family members in breast cancer: a study in primary tumors of high-risk early breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial

George Fountzilas, Christos Christodoulou, George Kouvatseas, 2012, Breast Cancer Research.

Genotyping KRAS and EGFR Mutations in Greek Patients With Non-small-cell Lung Cancer: Incidence, Significance and Implications for Treatment

K. Syrigos, K. Papadopoulou, G. Fountzilas, 2019, Cancer Genomics & Proteomics.

Primary fallopian tube carcinoma: results of a retrospective analysis of 64 patients.

T. Economopoulos, G. Fountzilas, C. Andreadis, 2009, Gynecologic oncology.

Treatment of Primary Fallopian Tube Carcinoma with Cisplatin‐Containing Chemotherapy

D. Pectasides, I. Varthalitis, V. Barbounis, 1994, American journal of clinical oncology.

The Role of Neoadjuvant Chemotherapy in the Treatment of Advanced Ovarian Cancer

D. Farmakis, D. Pectasides, A. Koumarianou, 2005, Oncology.

Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer Cases

M. Dimopoulos, F. Fostira, D. Yannoukakos, 2013, PloS one.

Randomized phase III clinical trial comparing the combination of capecitabine and oxaliplatin (CAPOX) with the combination of 5-fluorouracil, leucovorin and oxaliplatin (modified FOLFOX6) as adjuvant therapy in patients with operated high-risk stage II or stage III colorectal cancer

G. Fountzilas, G. Pentheroudakis, C. Scopa, 2015, BMC Cancer.

Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.

Jane E. Carpenter, Kristen S Purrington, Victoria L. Cafourek, 2014, Carcinogenesis.

Evaluation of the Prognostic and Predictive Value of HER-1/EGFR in Breast Cancer Patients Participating in a Randomized Study with Dose-Dense Sequential Adjuvant Chemotherapy

U. Dafni, H. Gogas, V. Kyriakou, 2008, Oncology.

Differential Response of Immunohistochemically Defined Breast Cancer Subtypes to Anthracycline-Based Adjuvant Chemotherapy with or without Paclitaxel

M. Dimopoulos, U. Dafni, H. Gogas, 2012, PloS one.

Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial

M. Dimopoulos, U. Dafni, H. Gogas, 2012, Breast Cancer Research and Treatment.

Ixabepilone Administered Weekly or Every Three Weeks in HER2-Negative Metastatic Breast Cancer Patients; A Randomized Non-Comparative Phase II Trial

C. Papadimitriou, G. Fountzilas, G. Pentheroudakis, 2013, PloS one.

H. Gogas, R. Wirtz, G. Fountzilas, 2012, Breast Cancer Research.

Mutations of the epidermal growth factor receptor tyrosine kinase domain and associations with clinicopathological features in non-small cell lung cancer patients.

G. Fountzilas, D. Pectasides, H. Linardou, 2006, Lung cancer.

Prognostic Significance of IGF-1 Signalling Pathway in Patients With Advanced Non-small Cell Lung Cancer

S. Giannouli, H. Gogas, A. Psyrri, 2019, AntiCancer Research.

alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies

H. Gogas, G. Fountzilas, G. Pentheroudakis, 2014, BMC Clinical Pathology.

Survival improvement of young patients, aged 16-23, with Hodgkin lymphoma (HL) during the last three decades.

T. Economopoulos, E. Papageorgiou, D. Pectasides, 2007, Anticancer research.

Combination chemotherapy with low doses of weekly Carboplatin and oral Etoposide in poor risk small cell lung cancer.

N. Pavlidis, H. Kalofonos, G. Fountzilas, 1999, Lung cancer.

Paclitaxel in Cisplatin or Carboplatin-Pretreated Ovarian Cancer

D. Pectasides, M. Kostopoulou, M. Papadopoulou, 1998, Oncology.

A randomized study of epirubicin monotherapy every four or every two weeks in advanced breast cancer. A Hellenic Cooperative Oncology Group study.

N. Pavlidis, G. Fountzilas, C. Bamia, 1997, Annals of oncology : official journal of the European Society for Medical Oncology.

Evaluation of the prognostic role of a panel of biomarkers in stage IB-IIIA non-small cell lung cancer patients.

G. Fountzilas, D. Pectasides, S. Murray, 2007, Anticancer research.

Epithelial ovarian carcinoma in younger vs older women: is age an independent prognostic factor? The Hellenic Oncology Cooperative Group experience

M. Dimopoulos, T. Economopoulos, H. Kalofonos, 2006, International Journal of Gynecologic Cancer.

The prognostic role of ephrin A2 and endothelial growth factor receptor pathway mediators in patients with advanced colorectal cancer treated with cetuximab.

Sabine Tejpar, George Fountzilas, George Kouvatseas, 2013, Clinical colorectal cancer.

Successful treatment with cyclosporine of thymoma-related aplastic anemia.

D. Pectasides, C. Kosmas, G. Papaxoinis, 2007, Anticancer research.

Lymphocyte Subpopulations and Interleukin Levels in High-Risk Melanoma Patients Treated With High-Dose Interferon A-2B

M. Mihm, H. Gogas, G. Paterakis, 2002, American journal of clinical oncology.

Kit expression in male germ cell tumors.

T. Economopoulos, G. Fountzilas, P. Arapantoni-Dadioti, 2007, Anticancer research.

Oxaliplatin plus high-dose leucovorin and 5-fluorouracil (FOLFOX 4) in platinum-resistant and taxane-pretreated ovarian cancer: a phase II study.

P. Kountourakis, T. Economopoulos, S. Raptis, 2004, Gynecologic oncology.

Molecularly targeted therapies in unresectable-metastatic gastric cancer: a systematic review.

M. Dimopoulos, C. Papadimitriou, D. Pectasides, 2011, Cancer treatment reviews.

Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes

E. Giannoulatou, H. Gogas, G. Lazaridis, 2016, Breast Cancer Research and Treatment.

Significance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) Study

H. Gogas, G. Aravantinos, K. Papadopoulou, 2015, PloS one.

Endothelial vascular toxicity from chemotherapeutic agents: preclinical evidence and clinical implications.

M. Dimopoulos, A. Soultati, G. Mountzios, 2012, Cancer treatment reviews.

A randomized phase III study comparing three anthracycline-free taxane-based regimens, as first line chemotherapy, in metastatic breast cancer

M. Dimopoulos, U. Dafni, H. Gogas, 2009, Breast Cancer Research and Treatment.

Carboplatin and paclitaxel in advanced or metastatic endometrial cancer.

A. Psyrri, T. Economopoulos, G. Fountzilas, 2008, Gynecologic oncology.

Predictive biomarkers to chemotherapy in patients with advanced melanoma receiving the combination of cisplatin--vinblastine--temozolomide (PVT) as first-line treatment: a study of the Hellenic Cooperative Oncology Group (HECOG).

H. Gogas, G. Fountzilas, G. Pentheroudakis, 2015, Anticancer research.

Randomized phase III study of 1 month versus 1 year of adjuvant high-dose interferon alfa-2b in patients with resected high-risk melanoma.

U. Dafni, H. Gogas, G. Fountzilas, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adjuvant Chemotherapy With Dacarbazine, Vindesine, and Cisplatin in Pathological Stage II Malignant Melanoma

D. Pectasides, I. Varthalitis, G. Asimakopoulos, 1994, American journal of clinical oncology.

Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials

M. Dimopoulos, U. Dafni, N. Pavlidis, 2013, BMC Cancer.

Gastric metastases originating from breast cancer: report of 8 cases and review of the literature.

A. Psyrri, T. Economopoulos, D. Pectasides, 2009, Anticancer research.

HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy

H. Gogas, R. Wirtz, G. Aravantinos, 2012, Journal of Translational Medicine.

Relapsed and De Novo Metastatic HER2‐positive Breast Cancer Treated With Trastuzumab: Tumor Genotypes and Clinical Measures Associated With Patient Outcome

E. Giannoulatou, G. Lazaridis, K. Papadopoulou, 2019, Clinical breast cancer.

Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study

H. Gogas, R. Wirtz, G. Aravantinos, 2015, Journal of Translational Medicine.

Paclitaxel and carboplatin as first-line chemotherapy combined with gefitinib (IRESSA) in patients with advanced breast cancer: a phase I/II study conducted by the Hellenic Cooperative Oncology Group

H. Gogas, C. Markopoulos, G. Fountzilas, 2005, Breast Cancer Research and Treatment.

Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial

N. Pavlidis, H. Gogas, R. Wirtz, 2009, Breast Cancer Research and Treatment.

Her-2 Protein Expression, Cellular Localization, and Gene Amplification in Colorectal Carcinoma

A. Psyrri, P. Kountourakis, T. Economopoulos, 2007, Applied immunohistochemistry & molecular morphology : AIMM.

Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas

A. Psyrri, P. Kountourakis, T. Economopoulos, 2006, BMC Cancer.

Dose-dense sequential adjuvant chemotherapy in the trastuzumab era: final long-term results of the Hellenic Cooperative Oncology Group Phase III HE10/05 Trial

H. Gogas, C. Papadimitriou, C. Markopoulos, 2022, British Journal of Cancer.

Prognostic significance of the sequential detection of circulating melanoma cells by RT–PCR in high-risk melanoma patients receiving adjuvant interferon

H. Gogas, D. Pectasides, A. Polyzos, 2002, British Journal of Cancer.

Low-grade mucosa-associated lymphoid tissue lymphoma: a retrospective analysis of 97 patients by the Hellenic Cooperative Oncology Group (HeCOG).

M. Dimopoulos, N. Pavlidis, T. Economopoulos, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Intramedullary spinal cord metastases in breast cancer: report of four cases and review of the literature

D. Pectasides, C. Kosmas, M. Nikolaou, 2004, Journal of Neuro-Oncology.

Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study

George Fountzilas, Anastasia G. Eleftheraki, George Pentheroudakis, 2011, Breast Cancer Research and Treatment.

The Role of CXCL13 and CXCL9 in Early Breast Cancer.

H. Gogas, R. Wirtz, K. Pavlakis, 2019, Clinical breast cancer.

Prognostic Impact of Src, CDKN1B, and JAK2 Expression in Metastatic Breast Cancer Patients Treated with Trastuzumab

G. Lazaridis, G. Aravantinos, T. Economopoulos, 2019, Translational oncology.

Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early‐stage breast cancer patients treated with anthracycline‐based adjuvant chemotherapy

M. Dimopoulos, H. Gogas, R. Wirtz, 2018, Cancer medicine.

Evaluation of the Prognostic Value of RANK, OPG, and RANKL mRNA Expression in Early Breast Cancer Patients Treated with Anthracycline-Based Adjuvant Chemotherapy

H. Gogas, R. Wirtz, C. Markopoulos, 2017, Translational oncology.

Association of osteopontin with specific prognostic factors and survival in adjuvant breast cancer trials of the Hellenic Cooperative Oncology Group

H. Gogas, R. Wirtz, G. Lazaridis, 2017, Journal of Translational Medicine.

Comparison of the Ability of Different Clinical Treatment Scores to Estimate Prognosis in High-Risk Early Breast Cancer Patients: A Hellenic Cooperative Oncology Group Study

H. Gogas, R. Wirtz, G. Lazaridis, 2016, PloS one.

Concomitant diagnosis of myeloproliferative neoplasm and non-Hodgkin's lymphoma in a patient with portal vein thrombosis.

F. Kontopidou, D. Pectasides, J. Koskinas, 2011, Anticancer research.

Phase II study of panitumumab combined with capecitabine and oxaliplatin as first-line treatment in metastatic colorectal cancer patients: clinical results including extended tumor genotyping

K. Syrigos, E. Giannoulatou, G. Fountzilas, 2018, Medical Oncology.

Correlation of MYC Gene and Protein Status With Breast Cancer Subtypes and Outcome of Patients Treated With Anthracycline‐Based Adjuvant Chemotherapy. Pooled Analysis of 2 Hellenic Cooperative Group Phase III Trials

H. Gogas, G. Aravantinos, G. Fountzilas, 2017, Clinical breast cancer.

A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer

G. Fountzilas, M. Dimopoulos, G. Fountzilas, 2010, Cancer Chemotherapy and Pharmacology.

Systemic chemotherapy in locally advanced and/or metastatic bladder cancer.

T. Economopoulos, D. Pectasides, M. Pectasides, 2006, Cancer treatment reviews.

Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid Classes

E. Giannoulatou, H. Gogas, G. Aravantinos, 2016, PloS one.

Weekly alternating non-cross-resistant chemotherapy for small cell lung cancer with a good prognosis: a study of the Hellenic Cooperative Oncology Group.

N. Pavlidis, G. Fountzilas, D. Pectasides, 1999, American journal of clinical oncology.

Association of ERCC1 SNPs with outcome in platinum-treated patients with advanced urothelial cancer: a Hellenic Cooperative Oncology Group study.

I. Adamakis, D. Pectasides, S. Murray, 2012, Pharmacogenomics.

Current chemotherapeutic options for the treatment of advanced bladder cancer: a review.

D. Pectasides, K. Laschos, K. Pliarchopoulou, 2013, Urologic oncology.

Weekly chemotherapy with docetaxel, gemcitabine and cisplatin in advanced transitional cell urothelial cancer: a phase II trial.

D. Pectasides, N. Mitakidis, A. Kouloubinis, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group.

M. Dimopoulos, D. Pectasides, C. Nicolaides, 2001, Annals of oncology : official journal of the European Society for Medical Oncology.

Expression of DNA repair and replication genes in non-small cell lung cancer (NSCLC): a role for thymidylate synthetase (TYMS)

George Fountzilas, Christos Christodoulou, K. Syrigos, 2012, BMC Cancer.

Carboplatin and Paclitaxel in Metastatic or Recurrent Cervical Cancer

A. Psyrri, T. Economopoulos, G. Fountzilas, 2009, International Journal of Gynecologic Cancer.

Efficacy and Safety of First-Line Everolimus Therapy Alone or in Combination with Octreotide in Gastroenteropancreatic Neuroendocrine Tumors. A Hellenic Cooperative Oncology Group (HeCOG) Study

G. Kaltsas, G. Fountzilas, G. Pentheroudakis, 2020, Biology.

Comparison of two different doses of ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced emesis.

A. Constantinou, D. Pectasides, M. Kostopoulou, 1997, Oncology.

Temozolomide in combination with celecoxib in patients with advanced melanoma. A phase II study of the Hellenic Cooperative Oncology Group.

H. Gogas, C. Markopoulos, G. Fountzilas, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Adjuvant and neoadjuvant chemotherapy in muscle invasive bladder cancer: literature review.

D. Pectasides, M. Pectasides, M. Nikolaou, 2005, European urology.

Paclitaxel, topotecan, and carboplatin in metastatic endometrial cancinoma: a Hellenic Co-operative Oncology Group (HeCOG) study.

M. Dimopoulos, G. Fountzilas, A. Bamias, 2008, Gynecologic oncology.

A randomized phase III trial of adjuvant chemotherapy with irinotecan, leucovorin and fluorouracil versus leucovorin and fluorouracil for stage II and III colon cancer: A Hellenic Cooperative Oncology Group study

M. Dimopoulos, G. Aravantinos, T. Economopoulos, 2011, BMC medicine.

Hodgkin's disease following extranodal non‐Hodgkin's lymphoma

J. Panayiotides, D. Pectasides, A. Athanassiou, 1995, European journal of haematology.

Prognostic Significance of ESR1 Gene Amplification, mRNA/Protein Expression and Functional Profiles in High-Risk Early Breast Cancer: A Translational Study of the Hellenic Cooperative Oncology Group (HeCOG)

M. Dimopoulos, N. Pavlidis, H. Gogas, 2013, PloS one.

Significance of the 13C-caffeine breath test for patients with cirrhosis

D. Pectasides, E. Hadziyannis, G. Papatheodoridis, 2014, Annals of gastroenterology.

Pegfilgrastim Administered on the Same Day with Dose-Dense Adjuvant Chemotherapy for Breast Cancer Is Associated with a Higher Incidence of Febrile Neutropenia as Compared to Conventional Growth Factor Support: Matched Case-Control Study of the Hellenic Cooperative Oncology Group

G. Aravantinos, G. Fountzilas, G. Pentheroudakis, 2008, Oncology.

Increasing frequency of gram‐positive cocci and gram‐negative multidrug‐resistant bacteria in spontaneous bacterial peritonitis

N. Papadopoulos, D. Pectasides, M. Toutouza, 2013, Liver international : official journal of the International Association for the Study of the Liver.

Squamous Cell Carcinoma Antigen, Tumor‐Associated Trypsin Inhibitor, and Carcinoembryonic Antigen for Monitoring Cervical Cancer

D. Pectasides, A. Athanassiou, L. Gogou, 1994, American journal of clinical oncology.

AGAPP: efficacy of first-line cisplatin, 5-fluorouracil with afatinib in inoperable gastric and gastroesophageal junction carcinomas. A Hellenic Cooperative Oncology Group study

G. Aravantinos, C. Petraki, A. Psyrri, 2021, Acta oncologica.

Pathogenic mutations and overall survival in 3,084 patients with cancer: the Hellenic Cooperative Oncology Group Precision Medicine Initiative

E. Giannoulatou, H. Gogas, Jianhua Zhang, 2020, Oncotarget.

Adult granulosa cell tumors of the ovary: a clinicopathological study of 34 patients by the Hellenic Cooperative Oncology Group (HeCOG).

T. Economopoulos, G. Fountzilas, C. Andreadis, 2008, Anticancer research.

p85 Protein Expression is Associated with Poor Survival in HER2-Positive Patients with Advanced Breast Cancer Treated with Trastuzumab

A. Psyrri, Anastasios Stofas, K. Pavlakis, 2015, Pathology & Oncology Research.

In Situ Quantitative Measurement of HER2mRNA Predicts Benefit from Trastuzumab-Containing Chemotherapy in a Cohort of Metastatic Breast Cancer Patients

Taiwo A. Togun, U. Dafni, J. Bordeaux, 2014, PloS one.

EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab

S. Tejpar, A. Psyrri, G. Fountzilas, 2014, Journal of Cancer Research and Clinical Oncology.

Clinical Significance of Germline Cancer Predisposing Variants in Unselected Patients with Pancreatic Adenocarcinoma

F. Fostira, C. Papadimitriou, G. Aravantinos, 2021, Cancers.

Squamous Cell Carcinoma Antigen (SCC), Carcinoembryonic Antigen (CEA), and Tumour-Associated Trypsin Inhibitor (TATI) for Monitoring Head and Neck Cancer

D. Pectasides, A. Athanassiou, L. Gogou, 1993, The International journal of biological markers.

Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory germ cell tumors: a phase II study.

D. Farmakis, D. Pectasides, M. Pectasides, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Impact of cancer patients' disease awareness on their family members' health‐related quality of life: a cross‐sectional survey

T. Economopoulos, K. Kamposioras, Fotios Anagnostopoulos, 2011, Psycho-oncology.

Prognostic Significance of VEGFC and VEGFR1 mRNA Expression According to HER2 Status in Breast Cancer: A Study of Primary Tumors from Patients with High-risk Early Breast Cancer Participating in a Randomized Hellenic Cooperative Oncology Group Trial.

H. Gogas, R. Wirtz, K. Pavlakis, 2015, Anticancer research.

First line combination chemotherapy with docetaxel and vinorelbine in advanced breast cancer. A phase II study.

M. Dimopoulos, C. Papadimitriou, G. Fountzilas, 2001, Anticancer research.

Dose-dense sequential adjuvant chemotherapy followed, as indicated, by trastuzumab for one year in patients with early breast cancer: first report at 5-year median follow-up of a Hellenic Cooperative Oncology Group randomized phase III trial

M. Dimopoulos, U. Dafni, N. Pavlidis, 2014, BMC Cancer.

Genetic mapping of pancreatic cancer by targeted next-generation sequencing in a cohort of patients managed with nab-paclitaxel-based chemotherapy or agents targeting the EGFR axis: a retrospective analysis of the Hellenic Cooperative Oncology Group (HeCOG)

K. Papadopoulou, G. Fountzilas, G. Pentheroudakis, 2019, ESMO Open.

Cisplatin-containing regimen in advanced or recurrent granulosa cell tumours of the ovary.

D. Pectasides, A. Athanassiou, N. Alevizakos, 1992, Annals of oncology : official journal of the European Society for Medical Oncology.

Paclitaxel and epirubicin versus paclitaxel and carboplatin as first-line chemotherapy in patients with advanced breast cancer: a phase III study conducted by the Hellenic Cooperative Oncology Group.

M. Dimopoulos, U. Dafni, H. Gogas, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Correlation of CYP1A1, GSTP1 and GSTM1 gene polymorphisms and lung cancer risk among smokers.

K. Syrigos, G. Voutsinas, D. Pectasides, 2012, Oncology letters.

Disease evolution and heterogeneity in bilateral breast cancer.

F. Fostira, E. Giannoulatou, K. Papadopoulou, 2016, American journal of cancer research.

Gemcitabine (G) vs gemcitabine-carboplatin (GCB) for patients with advanced non-small cell lung cancer (NSCLC) and PS:2. A prospective randomized phase II study of the Hellenic Co-Operative Oncology Group

I. Boukovinas, H. Kalofonos, D. Pectasides, 2004 .

K. Syrigos, T. Economopoulos, G. Fountzilas, 2012, BMC Cancer.

Efficacy of methotrexate/vinblastine/doxorubicin cisplatin combination in gemcitabine-pretreated patients with advanced urothelial cancer: a retrospective analysis.

M. Dimopoulos, D. Pectasides, A. Bamias, 2010, Open access journal of urology.

Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG)

M. Dimopoulos, K. Koutsoukos, A. Bamias, 2016, World Journal of Urology.

131I-labelled monoclonal antibody H17E2 in the detection of subcutaneous metastasis from gestational choriocarcinoma.

D. Pectasides, A. Cross, A. Epenetos, 1990, Anticancer research.

Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III trial

N. Pavlidis, H. Gogas, R. Wirtz, 2012, Cancer Chemotherapy and Pharmacology.

Evaluation of the prognostic value of HER-2 and VEGF in breast cancer patients participating in a randomized study with dose–dense sequential adjuvant chemotherapy

M. Dimopoulos, H. Gogas, C. Markopoulos, 2006, Breast Cancer Research and Treatment.

Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter, randomized, phase II study.

M. Dimopoulos, T. Economopoulos, H. Kalofonos, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Expression Patterns of Growth and Survival Genes with Prognostic Implications in Advanced Pancreatic Cancer.

G. Fountzilas, G. Pentheroudakis, C. Dervenis, 2016, Anticancer research.

First-line chemotherapy of non-seminomatous germ cell tumors(NSGCTs).

D. Pectasides, K. Pliarchopoulou, 2009, Cancer treatment reviews.

Clinicopathologic Significance of EGFR and Her‐2/neu in Colorectal Adenocarcinomas

A. Psyrri, P. Kountourakis, T. Economopoulos, 2006, Cancer journal.

G. Fountzilas, G. Pentheroudakis, C. Scopa, 2015, BMC Cancer.

Palliative chemotherapy in elderly patients with common metastatic malignancies: A Hellenic Cooperative Oncology Group registry analysis of management, outcome and clinical benefit predictors.

K. Syrigos, N. Pavlidis, G. Aravantinos, 2008, Critical reviews in oncology/hematology.

Liver Function Breath Tests for Differentiation of Steatohepatitis From Simple Fatty Liver in Patients With Nonalcoholic Fatty Liver Disease

D. Pectasides, D. Tiniakos, G. Papatheodoridis, 2014, Journal of clinical gastroenterology.

Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women

N. Pavlidis, H. Gogas, H. Kalofonos, 2006, Breast Cancer Research and Treatment.

Analysis of 7 immunohistochemical markers in male germ cell tumors demonstrates the prognostic significance of p53 and MIB-1.

T. Economopoulos, G. Fountzilas, P. Arapantoni-Dadioti, 2009, Anticancer research.

Molecular markers in extragonadal germ cell tumours: a matched case–control study

T. Economopoulos, G. Fountzilas, D. Pectasides, 2007, Histopathology.

Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials

H. Gogas, G. Aravantinos, A. Psyrri, 2015, Oncotarget.

Effects on blood coagulation of adjuvant CNF (cyclophosphamide, novantrone, 5-fluorouracil) chemotherapy in stage II breast cancer patients.

G. Fountzilas, D. Pectasides, D. Tsavdaridis, 1999, Anticancer research.

Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting

E. Terpos, D. Vassilopoulos, A. Andrikopoulou, 2023, The breast journal.

Pancreatic cancer: current and future treatment strategies.

D. Pectasides, K. Pliarchopoulou, 2009, Cancer treatment reviews.

Cirrhosis but not neutropenia is associated with the development of infection in patients with chronic hepatitis C undergoing treatment with pegylated interferon‐alpha and ribavirin

D. Pectasides, M. Deutsch, S. Manolakopoulos, 2014, Journal of viral hepatitis.

Prognostic significance of tumor genotypes and CD8+ infiltrates in stage I-III colorectal cancer

G. Aravantinos, A. Psyrri, K. Papadopoulou, 2018, Oncotarget.

Increased abdominal fat levels measured by bioelectrical impedance are associated with histological lesions of nonalcoholic steatohepatitis

Y. Manios, M. Kontogianni, D. Pectasides, 2015, European journal of gastroenterology & hepatology.

MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer

H. Gogas, G. Aravantinos, A. Psyrri, 2016, Journal of Translational Medicine.

Evaluation of the Insulin-like Growth Factor Receptor Pathway in Patients with Advanced Breast Cancer Treated with Trastuzumab

K. Papadopoulou, G. Fountzilas, G. Pentheroudakis, 2018, Cancer Genomics & Proteomics.

Reply to Prof. George Omura

D. Farmakis, D. Pectasides, 2005 .

Carboplatin and paclitaxel versus cisplatin, paclitaxel and doxorubicin for first-line chemotherapy of advanced ovarian cancer: a Hellenic Cooperative Oncology Group (HeCOG) study.

M. Dimopoulos, C. Papadimitriou, G. Aravantinos, 2008, European Journal of Cancer.

Clinical Significance of Major Angiogenesis-Related Effectors in Patients with Metastatic Breast Cancer Treated with Trastuzumab-Based Regimens

K. Pavlakis, K. Papadopoulou, G. Fountzilas, 2021, Cancer research and treatment.

Improved outcome of high-risk early HER2 positive breast cancer with high CXCL13-CXCR5 messenger RNA expression.

N. Pavlidis, H. Gogas, R. Wirtz, 2012, Clinical breast cancer.

Tumor Mutational Patterns and Infiltrating Lymphocyte Density in Young and Elderly Patients With Breast Cancer

E. Giannoulatou, H. Gogas, G. Aravantinos, 2020, Cancer Genomics & Proteomics.

Intensive weekly chemotherapy with docetaxel, epirubicin and carboplatin with G-CSF support in patients with advanced gastric cancer

H. Gogas, G. Aravantinos, H. Kalofonos, 2007, Medical oncology.

Immune Response Gene Expression in Colorectal Cancer Carries Distinct Prognostic Implications According to Tissue, Stage and Site: A Prospective Retrospective Translational Study in the Context of a Hellenic Cooperative Oncology Group Randomised Trial

K. Syrigos, R. Wirtz, G. Lazaridis, 2015, PloS one.

Safety and Tolerability of Anthracycline-Containing Adjuvant Chemotherapy in Elderly High-Risk Breast Cancer Patients.

M. Dimopoulos, H. Gogas, G. Aravantinos, 2016, Clinical breast cancer.

Genotype - phenotype associations in colorectal adenocarcinomas and their matched metastases.

E. Giannoulatou, K. Papadopoulou, G. Fountzilas, 2020, Human pathology.

AMALTHEA: Prospective, Single‐Arm Study of the Hellenic Cooperative Oncology Group (HeCOG) Evaluating Efficacy and Safety of First‐Line FOLFIRI + Aflibercept for 6 Months Followed by Aflibercept Maintenance in Patients With Metastatic Colorectal Cancer

G. Aravantinos, C. Petraki, G. Fountzilas, 2018, Clinical colorectal cancer.

Survivin and glycodelin transcriptional activity in node-positive early breast cancer: mRNA expression of two key regulators of cell survival

M. Dimopoulos, N. Pavlidis, H. Gogas, 2006, Breast Cancer Research and Treatment.

Complete response after imatinib mesylate administration in a patient with chemoresistant stage IV seminoma.

T. Economopoulos, D. Pectasides, A. Koumarianou, 2008, Anticancer research.

Irinotecan and gemcitabine in patients with advanced non-small cell lung cancer, previously treated with cisplatin-based chemotherapy. A phase II study.

D. Farmakis, D. Pectasides, C. Kosmas, 2003, Anticancer Research.

XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysis.

G. Fountzilas, N. Maniadakis, D. Pectasides, 2009, Current medical research and opinion.

XELOX versus FOLFOX6 as an adjuvant treatment in colorectal cancer: an economic analysis

G. Fountzilas, N. Maniadakis, D. Pectasides, 2009 .

Chronic myelogenous leukemia and colon cancer: A causal relationship or coincidence?

F. Kontopidou, D. Pectasides, T. Kanellopoulou, 2011, Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology.

Association of VEGF-A splice variant mRNA expression with outcome in bevacizumab-treated patients with metastatic breast cancer.

M. Dimopoulos, G. Fountzilas, G. Pentheroudakis, 2014, Clinical breast cancer.

Chemotherapy with cisplatin, epirubicin and docetaxel in transitional cell urothelial cancer. Phase II trial.

D. Pectasides, A. Athanassiou, A. Visvikis, 2000, European journal of cancer.

Two cases of complete response after imatinib mesylate treatment of advanced GIST.

T. Economopoulos, D. Pectasides, G. Papaxoinis, 2006, Anticancer research.

Phase II Window Study of Olaparib Alone or with Cisplatin or Durvalumab in Operable Head and Neck Cancer

D. Rimm, A. Psyrri, E. Kyrodimos, 2023, Cancer research communications.

Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study

H. Gogas, R. Wirtz, G. Aravantinos, 2015, Journal of Translational Medicine.

A pilot study of temozolomide as first line therapy of central nervous system metastases from malignant melanoma

E. Efstathiou, D. Pectasides, D. Skarlos, 2000 .

Detection of circulating tumor cells in breast cancer patients using multiplex reverse transcription-polymerase chain reaction and specific primers for MGB, PTHRP and KRT19 correlation with clinicopathological features.

M. Koutsilieris, D. Pectasides, E. Gkioka, 2014, Anticancer research.

Combination chemotherapy with carboplatin, paclitaxel and pegylated liposomal doxorubicin for advanced or recurrent carcinosarcoma of the uterus: clinical experience of a single institution.

T. Economopoulos, J. Panayiotides, D. Pectasides, 2008, Gynecologic oncology.

Reply to P. Mohr et al

U. Dafni, H. Gogas, D. Pectasides, 2009 .

Irinotecan/fluorouracil/leucovorin or the same regimen followed by oxaliplatin/fluorouracil/leucovorin in metastatic colorectal cancer.

G. Aravantinos, T. Economopoulos, K. Syrigos, 2010, Anticancer research.

Efficacy of methotrexate/vinblastine/doxorubicin cisplatin combination in gemcitabine-pretreated patients with advanced urothelial cancer: a retrospective analysis

M. Dimopoulos, D. Pectasides, A. Bamias, 2010, Open Access Journal of Urology.

Association of VEGF-A splice variant mRNA expression with outcome in bevacizumab-treated patients with metastatic breast cancer.

M. Dimopoulos, G. Fountzilas, G. Pentheroudakis, 2014, Clinical Breast Cancer.

G. Aravantinos, H. Kalofonos, G. Fountzilas, 2010, BMC medicine.

Prognostic significance of UBE2C mRNA expression in high-risk early breast cancer. A Hellenic Cooperative Oncology Group (HeCOG) Study.

N. Pavlidis, H. Gogas, R. Wirtz, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Left ventricle enlargement and increased systolic velocity in the mitral valve are indirect markers of the hepatopulmonary syndrome

C. Chrysochoou, D. Pectasides, G. Papatheodoridis, 2011, Liver international : official journal of the International Association for the Study of the Liver.

Common breast cancer susceptibility loci are associated with triple-negative breast cancer.

Jane E. Carpenter, S. Cross, M. Beckmann, 2011, Cancer research.

Anakinra for the management of resistant idiopathic recurrent pericarditis. Initial experience in 10 adult cases

C. Stefanadis, D. Vassilopoulos, D. Pectasides, 2014, Annals of the rheumatic diseases.

Chemotherapy for recurrent cervical cancer.

K. Kamposioras, D. Pectasides, G. Papaxoinis, 2008, Cancer treatment reviews.

Chemotherapy with Methotrexate, Carboplatin, Mitoxantrone (Novantrone) and Vincristine (Oncovin) in Transitional-Cell Urothelial Cancer

D. Pectasides, M. Kostopoulou, M. Papadopoulou, 1998, Oncology.

First-line chemotherapy of non-seminomatous germ cell tumors(NSGCTs).

D. Pectasides, K. Pliarchopoulou, 2009, Cancer treatment reviews.

Gynecologic Oncology Treatment Issues in Clear Cell Carcinoma of the Ovary: a Different Entity?

A. Psyrri, T. Economopoulos, D. Pectasides, 2022 .